Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas
US8338489B2 · kind B2 · utility
3Cited by
9References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 16, 2008 |
| Grant date | Dec 25, 2012 |
| Priority date | — |
| Expiry date | Oct 16, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates the use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas, for example of infantile hemangiomas. The beta blocker may be a non-selective beta-blocker, for example propranolol. The present disclosure provides an alternative to the known compounds, e.g. corticosteroids, interferon or vincristine, generally used for the treatment of hemangiomas.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.